- Home
- REGN vs FTNT Comparison
REGN vs FTNT Comparison
Compare REGN & FTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGN
- FTNT
- Stock Information
- Founded
- REGN 1988
- FTNT 2000
- Country
- REGN United States
- FTNT United States
- Employees
- REGN N/A
- FTNT N/A
- Industry
- REGN Biotechnology: Pharmaceutical Preparations
- FTNT Computer peripheral equipment
- Sector
- REGN Health Care
- FTNT Technology
- Exchange
- REGN Nasdaq
- FTNT Nasdaq
- Market Cap
- REGN 59.5B
- FTNT 61.5B
- IPO Year
- REGN 1991
- FTNT 2009
- Fundamental
- Price
- REGN $786.06
- FTNT $80.35
- Analyst Decision
- REGN Buy
- FTNT Hold
- Analyst Count
- REGN 23
- FTNT 31
- Target Price
- REGN $775.13
- FTNT $90.74
- AVG Volume (30 Days)
- REGN 1.1M
- FTNT 6.0M
- Earning Date
- REGN 10-28-2025
- FTNT 11-05-2025
- Dividend Yield
- REGN 0.45%
- FTNT N/A
- EPS Growth
- REGN 2.88
- FTNT 22.04
- EPS
- REGN 41.59
- FTNT 2.43
- Revenue
- REGN $14,247,800,000.00
- FTNT $6,554,700,000.00
- Revenue This Year
- REGN $1.34
- FTNT $15.60
- Revenue Next Year
- REGN $5.23
- FTNT $11.60
- P/E Ratio
- REGN $18.86
- FTNT $33.15
- Revenue Growth
- REGN 2.89
- FTNT 14.78
- 52 Week Low
- REGN $476.49
- FTNT $70.12
- 52 Week High
- REGN $800.99
- FTNT $114.82
- Technical
- Relative Strength Index (RSI)
- REGN 80.63
- FTNT 44.47
- Support Level
- REGN $651.38
- FTNT $77.17
- Resistance Level
- REGN $713.58
- FTNT $81.19
- Average True Range (ATR)
- REGN 22.69
- FTNT 2.21
- MACD
- REGN 8.55
- FTNT -0.17
- Stochastic Oscillator
- REGN 96.74
- FTNT 45.62
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
About FTNT Fortinet Inc.
Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.